loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 50207 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Azurity Pharma

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 AZURITY (3)

    filter

    01 GRANULE;ORAL (3)

    filter

    01 RX (3)

    filter

    01 E.E.S. (1)

    02 ERYPED (2)

    filter

    01 Yes (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
      Post an Enquiry Post an Enquiry
      Flag U.S.A
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      ERYTHROMYCIN ETHYLSUCCINATE

      PDF Supplier PDF
      URL Supplier Web Content
      GRANULE; ORAL
      EQ 400MG BASE/5ML
      1982-01-01
      50207
      ERYPED
      RX
      Yes
      AB
      ASK
      US
      PHARMACOMPASS
      Upload
      your Marketing & Sales content
      Contact Supplier
        Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
        Post an Enquiry Post an Enquiry
        Flag U.S.A
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        ERYTHROMYCIN ETHYLSUCCINATE

        PDF Supplier PDF
        URL Supplier Web Content
        GRANULE; ORAL
        EQ 200MG BASE/5ML
        1987-03-30
        50207
        ERYPED
        RX
        Yes
        AB
        ASK
        US
        PHARMACOMPASS
        Upload
        your Marketing & Sales content
        Contact Supplier
          Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
          Post an Enquiry Post an Enquiry
          Flag U.S.A
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          ERYTHROMYCIN ETHYLSUCCINATE

          PDF Supplier PDF
          URL Supplier Web Content
          GRANULE; ORAL
          EQ 200MG BASE/5ML
          1982-01-01
          50207
          E.E.S.
          RX
          Yes
          AB
          ASK
          US
          PHARMACOMPASS
          Upload
          your Marketing & Sales content

          Looking for FDA Orange Book APPLICATION 50207

          Looking for FDA Orange Book APPLICATION 50207 3

          19

          Azurity Pharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 50207.

          Regulatory Information RX

          With a dosage strength EQ 400MG BASE/5ML

          Dosage Form Route GRANULE; ORAL

          Reference Listed Drug Yes

          Approved since 1982-01-01

          Therapeutic Equivalence (TE) Code AB

          18

          Azurity Pharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 50207.

          Regulatory Information RX

          With a dosage strength EQ 200MG BASE/5ML

          Dosage Form Route GRANULE; ORAL

          Reference Listed Drug Yes

          Approved since 1987-03-30

          Therapeutic Equivalence (TE) Code AB

          17

          Azurity Pharma, based in U.S.A, is a pharmaceutical company.

          One of their notable products is ERYTHROMYCIN ETHYLSUCCINATE, with a corresponding application number 50207.

          Regulatory Information RX

          With a dosage strength EQ 200MG BASE/5ML

          Dosage Form Route GRANULE; ORAL

          Reference Listed Drug Yes

          Approved since 1982-01-01

          Therapeutic Equivalence (TE) Code AB

          Post Enquiry
          POST ENQUIRY